nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
|
Abbassi, Ramzi |
|
2015 |
151 |
C |
p. 87-98 12 p. |
artikel |
2 |
Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation
|
Liu, Ke |
|
2015 |
151 |
C |
p. 121-140 20 p. |
artikel |
3 |
Epigenomes as therapeutic targets
|
Hamm, Christopher A. |
|
2015 |
151 |
C |
p. 72-86 15 p. |
artikel |
4 |
Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin
|
Collino, Massimo |
|
2015 |
151 |
C |
p. 32-40 9 p. |
artikel |
5 |
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
|
Sampath, Deepak |
|
2015 |
151 |
C |
p. 16-31 16 p. |
artikel |
6 |
Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability
|
Clarke, John D. |
|
2015 |
151 |
C |
p. 99-106 8 p. |
artikel |
7 |
Pericytes, mesenchymal stem cells and their contributions to tissue repair
|
Wong, Suet-Ping |
|
2015 |
151 |
C |
p. 107-120 14 p. |
artikel |
8 |
PIM kinase (and Akt) biology and signaling in tumors
|
Warfel, Noel A. |
|
2015 |
151 |
C |
p. 41-49 9 p. |
artikel |
9 |
Targeting caveolin-3 for the treatment of diabetic cardiomyopathy
|
Murfitt, Lucy |
|
2015 |
151 |
C |
p. 50-71 22 p. |
artikel |
10 |
Targeting Cdc20 as a novel cancer therapeutic strategy
|
Wang, Lixia |
|
2015 |
151 |
C |
p. 141-151 11 p. |
artikel |
11 |
The clinical application of mesenchymal stem cells and cardiac stem cells as a therapy for cardiovascular disease
|
Kim, Jiyeon |
|
2015 |
151 |
C |
p. 8-15 8 p. |
artikel |
12 |
The organ-protective effect of N-type Ca2+ channel blockade
|
Kuwahara, Koichiro |
|
2015 |
151 |
C |
p. 1-7 7 p. |
artikel |